 Orexo has successfully formulated Covid-19 spike protein in the proprietary drug delivery platform amorphOX, showing excellent protein stability Orexo has initiated two exploratory feasibility studies applying amorphOX to a protein based pharmaceutical and a vaccine in collaboration with leading international biopharmaceutical and vaccine companies Orexo has patent applications for amorphOX formulations relating to biomolecules UPPSALA, ...... 